Literature DB >> 18818027

Clinical characteristics of treatment-seeking adolescents with opioid versus cannabis/alcohol use disorders.

Geetha A Subramaniam1, Maxine L Stitzer, George Woody, Marc J Fishman, Ken Kolodner.   

Abstract

OBJECTIVES: To assess the clinical characteristics of adolescents with DSM-IV opioid use disorder (OUD) and compare them to adolescents with cannabis/alcohol use disorders.
METHOD: 94 adolescents (ages 14-18 years) with a current OUD and 74 adolescents with a current non-OUD cannabis/alcohol use disorders were recruited from admissions, predominantly residential, to a substance abuse treatment program in Baltimore, ML. Participants were assessed cross-sectionally using standardized interviews and self-reports. Chi-square, t-tests and ANCOVA (adjusting for age, gender and treatment setting, race and residence) were performed to determine group differences on demographic, substance use, psychiatric and HIV-risk behaviors; logistic regression analyses, both unadjusted and adjusted for the above five factors were conducted to assess the strength of associations.
RESULTS: The OUD group was more likely to be Caucasian, to have dropped out of school and to live in the suburbs (trend). They also had greater substance use severity with higher proportion of current sedative and multiple substance use disorders (SUD). There were generally no differences in rates of criminal behaviors. Both groups had high rates of current psychiatric disorders (83% vs. 78%, n.s.) but the OUD adolescents reported higher depressive symptoms, mostly in the moderate range. Injection drug use (IDU) and needle sharing was almost exclusive to the OUD group, while both groups reported similar high rates of risky sexual behaviors.
CONCLUSIONS: While there were similarities between the two groups, OUD adolescents evidenced greater impairment in academic, substance use, depressive symptom and IDU-related HIV-risk areas. Findings suggest poorer long-term prognosis and highlight the need for specialized interventions for treatment-seeking OUD adolescents.

Entities:  

Mesh:

Year:  2008        PMID: 18818027      PMCID: PMC2758688          DOI: 10.1016/j.drugalcdep.2008.07.016

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  29 in total

1.  One-year mortality rates following methadone treatment discharge.

Authors:  D A Zanis; G E Woody
Journal:  Drug Alcohol Depend       Date:  1998-11-01       Impact factor: 4.492

2.  Psychiatric disorders associated with substance use among children and adolescents: findings from the Methods for the Epidemiology of Child and Adolescent Mental Disorders (MECA) Study.

Authors:  D B Kandel; J G Johnson; H R Bird; G Canino; S H Goodman; B B Lahey; D A Regier; M Schwab-Stone
Journal:  J Abnorm Child Psychol       Date:  1997-04

3.  The reliability of the CIDI-SAM: a comprehensive substance abuse interview.

Authors:  L B Cottler; L N Robins; J E Helzer
Journal:  Br J Addict       Date:  1989-07

4.  Dimensions of the Beck Depression Inventory-II in clinically depressed outpatients.

Authors:  R A Steer; R Ball; W F Ranieri; A T Beck
Journal:  J Clin Psychol       Date:  1999-01

5.  Psychiatric and substance use comorbidity among treatment-seeking opioid abusers.

Authors:  R K Brooner; V L King; M Kidorf; C W Schmidt; G E Bigelow
Journal:  Arch Gen Psychiatry       Date:  1997-01

6.  Psychiatric disorders in substance-abusing adolescent inpatients: a pilot study.

Authors:  R J Stowell; T W Estroff
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1992-11       Impact factor: 8.829

7.  Patterns of affective comorbidity in a clinical population of dually diagnosed adolescent substance abusers.

Authors:  O G Bukstein; L J Glancy; Y Kaminer
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1992-11       Impact factor: 8.829

8.  Reliability, validity, and parent-child agreement studies of the Diagnostic Interview for Children and Adolescents (DICA).

Authors:  Z Welner; W Reich; B Herjanic; K G Jung; H Amado
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1987-09       Impact factor: 8.829

9.  Depression in substance-dependent delinquents.

Authors:  P D Riggs; S Baker; S K Mikulich; S E Young; T J Crowley
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1995-06       Impact factor: 8.829

10.  Psychiatric comorbidity in hospitalized adolescent substance abusers.

Authors:  J G Hovens; D P Cantwell; R Kiriakos
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1994-05       Impact factor: 8.829

View more
  25 in total

1.  Pharmacotherapy for Substance Use Disorders in Youths.

Authors:  Christopher J Hammond; Kevin M Gray
Journal:  J Child Adolesc Subst Abuse       Date:  2016-04-20

2.  Pharmacologically assisted treatment of opioid-dependent youth.

Authors:  Anna Pecoraro; Marc Fishman; Michelle Ma; Gvantsa Piralishvili; George E Woody
Journal:  Paediatr Drugs       Date:  2013-12       Impact factor: 3.022

3.  Cost-effectiveness of extended buprenorphine-naloxone treatment for opioid-dependent youth: data from a randomized trial.

Authors:  Daniel Polsky; Henry A Glick; Jianing Yang; Geetha A Subramaniam; Sabrina A Poole; George E Woody
Journal:  Addiction       Date:  2010-07-12       Impact factor: 6.526

4.  Major Depression and Risky Sexual Behavior among Substance Dependent Patients: The Moderating Roles of Distress Tolerance and Gender.

Authors:  Matthew T Tull; Kim L Gratz
Journal:  Cognit Ther Res       Date:  2013-06-01

5.  Perceived health, medical, and psychiatric conditions in individual and dual-use of marijuana and nonprescription opioids.

Authors:  Tessa Frohe; Cheryl L Beseler; Andres M Mendoza; Linda B Cottler; Robert F Leeman
Journal:  J Consult Clin Psychol       Date:  2019-10

Review 6.  Treatment of opioid-dependent adolescents and young adults with buprenorphine.

Authors:  Geetha A Subramaniam; Marc J Fishman; George Woody
Journal:  Curr Psychiatry Rep       Date:  2009-10       Impact factor: 5.285

7.  Association of cannabis use with opioid outcomes among opioid-dependent youth.

Authors:  Kevin P Hill; Heather E Bennett; Margaret L Griffin; Hilary S Connery; Garrett M Fitzmaurice; Geetha Subramaniam; George E Woody; Roger D Weiss
Journal:  Drug Alcohol Depend       Date:  2013-03-22       Impact factor: 4.492

8.  Clinical characteristics of treatment-seeking prescription opioid vs. heroin-using adolescents with opioid use disorder.

Authors:  Geetha A Subramaniam; Maxine A Stitzer
Journal:  Drug Alcohol Depend       Date:  2008-12-09       Impact factor: 4.492

9.  Adolescent Community Reinforcement Approach implementation and treatment outcomes for youth with opioid problem use.

Authors:  Mark D Godley; Lora L Passetti; Geetha A Subramaniam; Rodney R Funk; Jane Ellen Smith; Robert J Meyers
Journal:  Drug Alcohol Depend       Date:  2017-02-22       Impact factor: 4.492

Review 10.  The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use Disorders.

Authors:  Christopher J Hammond
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2016-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.